Source: Associated Press
Publication Date: June 10, 2016
The FDA approves the PaxVax oral cholera vaccine for adults aged 18-64 who are traveling to countries affected by cholera.
It’s an exciting time to join PaxVax. If you’re looking for an opportunity in healthcare to drive creativity, collaboration and innovation, we’d like to hear from you.